Publication: The effect of different dosage regimens of tranexamic acid on blood loss in bimaxillary osteotomy: a randomized, double-blind, placebo-controlled study
Issued Date
2018-05-01
Resource Type
ISSN
13990020
09015027
09015027
Other identifier(s)
2-s2.0-85032961587
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Oral and Maxillofacial Surgery. Vol.47, No.5 (2018), 608-612
Suggested Citation
B. Apipan, D. Rummasak, T. Narainthonsaenee The effect of different dosage regimens of tranexamic acid on blood loss in bimaxillary osteotomy: a randomized, double-blind, placebo-controlled study. International Journal of Oral and Maxillofacial Surgery. Vol.47, No.5 (2018), 608-612. doi:10.1016/j.ijom.2017.10.007 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/45710
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The effect of different dosage regimens of tranexamic acid on blood loss in bimaxillary osteotomy: a randomized, double-blind, placebo-controlled study
Author(s)
Other Contributor(s)
Abstract
© 2017 International Association of Oral and Maxillofacial Surgeons The purpose of this study was to compare the effects of three dosage regimens of intravenous tranexamic acid and normal saline placebo on blood loss and the requirement for transfusion during bimaxillary osteotomy. A prospective, randomized, double-blind, placebo-controlled study was performed. Eighty patients scheduled for elective bimaxillary osteotomy were divided into four groups: a placebo group and three groups receiving a single dose of tranexamic acid 10, 15, or 20 mg/kg body weight after the induction of anaesthesia. Demographic data, the anaesthetic time, the operative time, and the experience of the surgical team were similar in the four groups. Patients receiving placebo had increased blood loss compared to those receiving tranexamic acid. No significant difference in blood loss was found among those who received 10, 15, or 20 mg/kg body weight of tranexamic acid. There was no significant difference in transfusion requirement, amount of 24-h postoperative vacuum drainage, length of hospital stay, or complications among the four groups. Prophylactic tranexamic acid decreased bleeding during bimaxillary osteotomy. Of the three dosages of tranexamic acid studied, the most efficacious and cost-effective dose to reduce bleeding was 10 mg/kg body weight.